Clinical trial
High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly…
NCT00428883 · Università Politecnica delle Marche, Other · Unknown status
Key facts
| NCT number | NCT00428883 |
|---|---|
| Title | High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis |
| Official title | Rare Disease With Microvascular Involvement: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis |
| Lead sponsor | Università Politecnica delle Marche, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Scleroderma, Diffuse |
| Intervention type | Drug |
| Interventions | N-acetylcysteine (NAC) |
| Enrollment | 45 |
| Start date | Jan 1, 2007 |
| Completion | Feb 1, 2009 |
| First posted | Jan 30, 2007 |
| Last update posted | Jan 30, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: